4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow shanchol: new trials by email Literature Review of shanchol trials Research Report on shanchol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ Oral Cholera Vaccine Simplified (OCV-S), Shanchol™ - Cholera | Phase 3 | Completed | International Vaccine Institute | 2530 | 2021-10-06 | 2023-06-22 |
| A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell - Cholera | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 336 | 2015-04-01 | 2018-03-26 |
| To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children Euvichol, Shanchol - Prevention Harmful Effects | Phase 3 | Completed | EuBiologics Co.,Ltd | 3632 | 2014-05-01 | 2014-12-08 |
| Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh Shanchol, Placebo - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 204438 | 2012-12-09 | 2018-03-20 |
Cholera (3)
EuBiologics Co.,Ltd (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · International Vaccine Institute (1) · Sanofi Pasteur, a Sanofi Company (1)
Bangladesh (1) · Dominican Republic (1) · Nepal (1) · Philippines (1)
Julia Lynch, MD (1) · Roberto A. Espos, MD (1)
PMID 19761838, PMID 21907255, PMID 24161413, PMID 27144848, PMID 29470934, PMID 29550406, PMID 31092224, PMID 31879124, PMID 38614631